Medical Policies and Clinical UM Guidelines
Medical Policies are used by all plans and lines of business unless federal or state law — as well as contract language, including definitions and specific contract provisions or exclusions — take precedence over a Medical Policy. Those provisions will be considered first in determining eligibility for coverage before the medical policy is used to determine medical necessity.
Clinical Utilization Management Guidelines
The Clinical Utilization Management (UM) Guidelines published on this website are not always used by all plans or lines of business. Clinical UM Guidelines are available for adoption to review the medical necessity of services related to the guideline when Healthy Blue performs a utilization review for the subject. Because practice patterns, claims systems and benefit designs vary, a local plan may choose whether to adopt a particular Clinical UM Guideline.
Health plans or lines of business that determine there is not a need to adopt a Clinical UM Guideline may instead use the guideline for educational purposes or to review the medical necessity of services for any provider who has been notified that his or her claims will be reviewed due to billing practices or claims that are inconsistent with other providers.
To determine which Clinical UM Guidelines have been adopted by your plan, or to determine if there are other applicable criteria, you can use the guideline adoption link provided below.
MCG Care Guidelines
MCG Care Guidelines are licensed and utilized to guide utilization management decisions for some health plans. This may include but is not limited to decisions involving prior authorization, inpatient review, level of care, discharge planning and retrospective review. MCG Care Guidelines licensed include:
- Inpatient & Surgical Care
- General Recovery Care
- Recovery Facility Care
- Chronic Care
- Behavioral Health Care
This document provides a summary of customizations to the MCG Care Guidelines 24th Edition (Publish date January 20, 2021).
Customizations to MCG Care Guidelines 24th Edition
This document provides a summary of customizations to the MCG Care Guidelines 25th Edition (Publish date August 19, 2021).
Customizations to MCG Care Guidelines 25th Edition
This document provides a summary of customizations to the MCG Care Guidelines 26th Edition (Publish date June 17, 2022).
Customizations to MCG Care Guidelines 26th Edition
AIM Specialty Health®
Our health plans may use guidelines developed by AIM Specialty Health (AIM) to perform utilization management services for some procedures and certain members.
AIM guidelines applicable to Healthy Blue programs are maintained by AIM Specialty Health. Updates to these guidelines can be found on their website.
IngenioRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the plan. Clinical criteria for drugs and biologics paid under the medical benefit for certain Medicare/Medicaid markets can be found on the IngenioRx website.
The pharmacy clinical criteria for injectable, infused or implanted prescription drugs and therapies covered under the medical benefit are available for certain Medicare/Medicaid markets.
Publish date — the date a Medical Policy or Clinical UM Guideline was made available on our public websites
Last review date — the date a Medical Policy or Clinical UM Guideline was reviewed and approved
Note that while a publish date is enterprisewide, the implementation date may differ depending on notification requirements. Please refer to the Healthy Blue Provider Newsletter for more information relating to implementation dates.
If a medical policy or clinical UM guideline is not yet implemented for your Plan, historical versions may be accessed.
To see a list of all Medical Policies and Clinical UM Guidelines, visit our Full List page.